The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: A review

Scandinavian Journal of Immunology

Volumn 72, Issue 3, 2010, Pages 235-241

  Hutter, D ^a,b   Silverman, E D ^a   Jaeggi, E T ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAMETHASONE; DEXAMETHASONE; IMMUNOGLOBULIN; INOTROPIC AGENT; MATERNAL ANTIBODY; RO ANTIBODY; SALBUTAMOL; STEROID; TERBUTALINE; ANTINUCLEAR ANTIBODY; SS-A ANTIBODIES;

ATRIOVENTRICULAR BLOCK; CEREBRAL PALSY; COMPLETE HEART BLOCK; CONGENITAL HEART BLOCK; CONGESTIVE CARDIOMYOPATHY; DRUG DOSE REDUCTION; DRUG MEGADOSE; ENDOCARDIAL FIBROELASTOSIS; FETUS HEART RATE; FETUS RISK; FIBROSIS; FLUID RETENTION; GESTATION PERIOD; GLUCOSE INTOLERANCE; HEADACHE; HEALING; HEART ARRHYTHMIA; HEART ATRIUM CONTRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PALPITATION; HEART VENTRICLE FILLING; HIRSUTISM; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; INFECTION SENSITIVITY; INFLAMMATION; INSOMNIA; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; LUNG EDEMA; MATERNAL HYPERTENSION; MOOD CHANGE; MORTALITY; MYOCARDIAL DISEASE; OLIGOHYDRAMNIOS; PLACENTAL TRANSFER; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; STOMACH IRRITATION; STRIA; SURVIVAL; SWEATING; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN; WOUND HEALING IMPAIRMENT; FEMALE; FETAL DISEASES; FETAL THERAPY; FETOMATERNAL TRANSFUSION; IMMUNOLOGY; PREGNANCY; PROCEDURES;

ADRENERGIC BETA-AGONISTS; ANTIBODIES, ANTINUCLEAR; ATRIOVENTRICULAR BLOCK; FEMALE; FETAL DISEASES; FETAL THERAPIES; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; STEROIDS;

EID: 77955289906     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02440.x     Document Type: Review

References (85)

1. Lee LA, Bias WB, Arnett FC Jr. et al. Immunogenetics of the neonatal lupus syndrome. Ann Intern Med 1983 99 : 592 596.
2. Watson RM, Lane AT, Barnett NK, Bias WB, Arnett FC, Provost TT. Neonatal lupus erythematosus. A clinical, serological and immunogenetic study with review of the literature. Medicine 1984 63 : 362 378.
3. Buyon JP, Ben-Chetrit E, Karp S et al. Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest 1989 84 : 627 634.
4. Silverman ED, Buyon J, Laxer RM et al. Autoantibody response to the Ro/La particle may predict outcome in neonatal lupus erythematosus. Clin Exp Immunol 1995 100 : 499 505.
5. Schmidt KG, Ulmer HE, Silverman NH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991 17 : 1360 1366.
6. Taylor PV, Taylor KF, Norman A, Griffiths S, Scott JS. Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block. Br J Rheumatol 1988 27 : 128 132.
7. Gladman G, Silverman ED, Law Y et al. Fetal echocardiographic screening of pregnancies of mothers with anti-Ro and/or anti-La antibodies. Am J Perinatol 2002 19 : 73 80.
8. Waltuck J, Buyon JP. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994 120 : 544 551.
9. Brucato A, Frassi M, Franceschini F et al. A Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmuno-electrophoresis: a prospective study of 100 women. Arthritis Rheum 2001 44 : 1832 1835.
10. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004 50 : 3187 3194.
11. Jaeggi ET, Laskin CA, Hamilton RM, Kingdom J, Silverman ED. The importance of maternal anti-Ro/SSA antibodies as prognostic markers of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 2010 55 : 2778 2784.
12. Deng JS, Bair LW Jr., Shen-Schwarz S, Ramsey-Goldman R, Medsger T Jr. Localization of Ro (SS-A) antigen in the cardiac conduction system. Arthritis Rheum 1987 30 : 1232 1238.
13. Chen X, Wolin SL. The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity. J Mol Med 2004 82 : 232 239.
14. Espinosa A, Zhou W, Ek M et al. The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death. J Immunol 2006 176 : 6277 6285.
15. Espinosa A, Dardalhon V, Brauner S et al. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway. J Exp Med 2009 206 : 1661 1671.
16. Xue D, Shi H, Smith JD et al. A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci U S A 2003 100 : 7503 7508.
17. Miranda ME, Tseng CE, Rashbaum W et al. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 1998 161 : 5061 5069.
18. Clancy RM, Neufing PJ, Zheng P et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 2006 116 : 2413 2422.
19. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004 50 : 173 182.
20. Clancy RM, Backer CB, Yin X, Kapur RP, Molad Y, Buyon JP. Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003 171 : 3253 3261.
21. Nield LE, Silverman ED, Taylor GP et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 2002 105 : 843 848.
22. Machado MV, Tynan MJ, Curry PV, Allan LD. Fetal complete heart block. Br Heart J 1988 60 : 512 515.
23. Groves AM, Allan LD, Rosenthal E. Outcome of isolated congenital complete heart block diagnosed in utero. Heart 1996 75 : 190 194.
24. Finkelstein Y, Adler Y, Harel L, Nussinovitch M, Youinou P. Anti-Ro (SSA) and anti-La (SSB) antibodies and complete congenital heart block. Ann Med Interne 1997 148 : 205 208.
25. Buyon JP, Hiebert R, Copel J et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998 31 : 1658 1666.
26. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution's experience of 30 years. J Am Coll Cardiol 2002 39 : 130 137.
27. Lopes LM, Tavares GM, Damiano AP et al. Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution. Circulation 2008 118 : 1268 1275.
28. Jaeggi E, Golding F, Silverman E. Letter to the Editor regarding article by Lopes et al."Perinatal outcome of fetal atrioventricular block: one-hundred sixteen cases from a single institution". Circulation 2009 119 : e539.
29. Marijon E, Costedoat-Chalumeau N, Georgin-Lavialle S, Fermont L, Bonnet D, Villain E. Prognosis of isolated atrioventricular block in children. Single center study of 135 cases. Arch Mal Coeur Vaiss 2007 100 : 912 916.
30. Breur JM, Kapusta L, Stoutenbeek P, Visser GH, van den Berg P, Meijboom EJ. Isolated congenital atrioventricular block diagnosed in utero: natural history and outcome. J Matern Fetal Neonatal Med 2008 21 : 469 476.
31. Moak JP, Barron KS, Hougen TJ et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001 37 : 238 242.
32. Udink ten Cate FE, Breur JM, Cohen MI et al. Dilated cardiomyopathy in isolated congenital complete atrioventricular block: early and long-term risk in children. J Am Coll Cardiol 2001 37 : 1129 1134.
33. Crawford SG, Kaplan BJ, Kinsbourne M. The effects of parental immunoreactivity on pregnancy, birth, and cognitive development: maternal immune attack on the fetus? Cortex 1992 28 : 483 491.
34. Ross G, Sammaritano L, Nass R, Lockshin M. Effects of mothers' autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 2003 157 : 397 402.
35. Urowitz MB, Gladman DD, MacKinnon A et al. Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus. Lupus 2008 17 : 555 560.
36. Buyon JP, Swersky SH, Fox HE, Bierman FZ, Winchester RJ. Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythemathosus. Experience in a mother with a predominance of SS-B (La) antibodies. Arthritis Rheum 1987 30 : 44 9.
37. Bierman FZ, Baxi L, Jaffe I, Driscoll J. Fetal hydrops and congenital complete heart block: response to maternal steroid therapy. J Pediatr 1988 112 : 646 648.
38. Carreira PE, Gutierrez-Larraya F, Gomez-Reino JJ. Successful intrauterine therapy with dexamethasone for fetal myocarditis and heart block in a woman with systemic lupus erythematosus. J Rheumatol 1993 20 : 1204 1207.
39. Saleeb S, Copel J, Friedman D et al. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block. Arthritis Rheum 1999 42 : 2335 2345.
40. Jaeggi ET, Fouron JC, Silverman ED, Ryan G, Smallhorn J, Hornberger LK. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease. Circulation 2004 110 : 1542 1548.
41. Kaaja R, Julkunen H, Ammala P, Teppo AM, Kurki P. Congenital heart block: successful prophylactic treatment with intravenous gamma globulin and corticosteroid therapy. Am J Obstet Gynecol 1991 165 : 1333 1334.
42. Kaaja R, Julkunen H. Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al. Arthritis Rheum 2003 62 : 1010 1012.
43. Barclay CS, French MA, Ross LD, Sokol RJ. Successful pregnancy following steroid therapy and plasma exchange in a woman with anti-Ro (SS-A) antibodies. Case report. Br J Obstet Gynaecol 1987 94 : 369 371.
44. van der Leij JN, Visser GH, Bink-Boelkens MT, Meilof JF, Kallenberg CG. Successful outcome of pregnancy after treatment of maternal anti-Ro (SSA) antibodies with immunosuppressive therapy and plasmapheresis. Prenat Diagn 1994 14 : 1003 1007.
45. Makino S, Yonemoto H, Itoh S, Takeda S. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjogren's syndrome. Acta Obstet Gynecol Scan. 2007 86 : 1145 1146.
46. Miyakata S, Takeuchi K, Yamaji K, Kanai Y, Tsuda H, Takasaki Y. Therapeutic plasmapheresis for the prevention of congenital complete heart block associated with anti-SS-A/Ro antibody and anti-SS-B/La antibody. Ryumachi 2001 41 : 726 735.
47. Carpenter RJ Jr., Strasburger JF, Garson A Jr., Smith RT, Deter RL, Engelhardt HT Jr. Fetal ventricular pacing for hydrops secondary to complete atrioventricular block. J Am Coll Cardiol 1986 8 : 1434 1436.
48. Walkinshaw SA, Welch CR, McCormack J et al. In utero pacing for fetal congenital heart block. Fetal Diagn Ther 1994 9 : 183 185.
49. Groves AMM, Allan LD, Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 1995 92 : 3394 3396.
50. Martin TC, Arias F, Olander DS et al. Successful management of congenital atrioventricular block associated with hydrops fetalis. J Pediatr 1988 112 : 984 986.
51. Harris JP, Alexson CG, Manning JA, Thompson HO. Medical therapy for the hydropic fetus with congenital complete atrioventricular block. Am J Perinatol 1993 10 : 217 219.
52. Copel JA, Buyon JP, Kleinman CS. Successful in utero therapy of fetal heart block. Am J Obstet Gynecol 1995 173 : 1384 1390.
53. Cuneo BF, Zhao H, Strasburger JF, Ovadia M, Huhta JC, Wakai RT. Atrial and ventricular rate response and patterns of heart rate acceleration during maternal-fetal terbutaline treatment of fetal complete heart block. Am J Cardiol 2007 100 : 661 665.
54. Pisoni CN, Brucato A, Ruffatti A et al. Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum 2010 62 : 1147 1152.
55. Lee BH, Stoll BJ, McDonald SA, Higgins RD. Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone. Pediatrics 2008 121 : 289 296.
56. Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006 3 : CD004454.
57. Wapner RJ, Sorokin Y, Mele L et al. Long-term outcomes after repeated doses of antenatal corticosteroids. N Eng J Med 2007 20 : 357.
58. Moss TJ, Sloboda DM, Gurrin LC, Harding R, Challis JR, Newnham JP. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Comp Physiol 2001 281 : R960 70.
59. Johnson JW, Mitzner W, London WT, Palmer AE, Scott R. Betamethasone and the rhesus fetus: multisystemic effects. Am J Obstet Gynecol 1979 133 : 677 684.
60. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999 180 : 114 121.
61. Banks BA, Cnaan A, Morgan MA et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 1999 181 : 709 717.
62. Canterino JC, Verma U, Visintainer PF, Eliman A, Klein S, Tejani N. Antenatal steroids and neonatal periventricular leucomalacia. Obstet Gynecol 2001 97 : 135 139.
63. Agarwal R, Chiswick ML, Rimmer S et al. Antenatal steroids are associated with a reduction in the incidence of cerebral white matter lesions in very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 2002 86 : F96 101.
64. Modi N, Lewis H, Al-Naqeeb N, Ajayi-Obe M, Doré CJ, Rutherford M. The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res 2001 50 : 581 585.
65. Parikh NA, Lasky RE, Kennedy KA et al. Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants. Pediatrics 2007 119 : 265 272.
66. Schmand B, Neuvel J, Smolders-de HaasH, Hoeks J, Treffers PE, Koppe JG. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics 1990 86 : 58 64.
67. Smolders-de Haas H, Neuvel J, Schmand B, Treffers PE, Koppe JG, Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics 1990 86 : 65 70. (Pubitemid 20198459)
68. Doyle LW, Ford GW, Rickards AL et al. Antenatal corticosteroids and outcome at 14 years of age in children with birth weight less than 1501 grams. Pediatrics 2000 106 : E2.
69. Dessens AB, Haas HS, Koppe JG. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics 2000 105 : E77.
70. Brucato A, Astori MG, Cimaz R et al. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero. Ann Rheum Dis 2006 65 : 1422 1426.
71. Finley J, Katz M, Rojas-Perez M, Roberts JM, Creasy RK, Schiller NB. Cardiovascular consequences of beta-agonist tocolysis: an echocardiographic study. Obstet Gynecol 1984 64 : 787 791.
72. Räsänen J. The effects of ritodrine infusion on fetal myocardial function and fetal hemodynamics. Acta Obstet Gynecol Scand 1990 69 : 487 492.
73. Boulton DW, Fawcett JP, Fiddes TM. Transplacental distribution of salbutamol enantiomers at caesarian section. Br J Clin Pharmacol 1997 44 : 587 590.
74. Benedetti TJ. Maternal complications of parenteral beta-sympathomimetic therapy for premature labor. Am J Obstet Gynecol 1983 145 : 1 6.
75. Ben-Shlomo I, Zohar S, Marmor A, Blondheim DS, Sharir T. Myocardial ischemia during intravenous ritodrine treatment: is it so rare? Lancet 1986 8512 : 917 918.
76. Pisani RJ, Rosenow EC III. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 1989 110 : 714 718.
77. Rosenthal D, Friedman DM, Buyon J, Dubin A. Validation of the Doppler PR interval in the fetus. J Am Soc Echocardiogr 2002 15 : 1029 1030.
78. Van Bergen AH, Cuneo BF, Davis N. Prospective echocardiographic evaluation of atrioventricular conduction in fetuses with maternal Sjögren's antibodies. Am J Obstet Gynecol 2004 191 : 1014 1018.
79. Raboisson MJ, Fouron JC, Sonesson SE, Nyman M, Proulx F, Gamache S. Fetal Doppler echocardiographic diagnosis and successful steroid therapy of Luciani-Wenckebach phenomenon and endocardial fibroelastosis related to maternal anti-Ro and anti-La antibodies. J Am Soc Echocardiogr 2005 18 : 375 380.
80. Friedman DM, Kim MY, Copel JA et al. PRIDE Investigators Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 2008 117 : 485 493.
81. Rein AJ, Mevorach D, Perles Z et al. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies. Circulation 2009 119 : 1867 1872.
82. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004 50 : 1253 1261.
83. Jaeggi E, Silverman E, Golding F, Laskin C, Kingdom J, Weber R. Prolongation of the atrio-ventricular conduction in fetuses exposed to maternal anti-Ro/La antibodies does not predict progressive heart block. Circulation 2009 120 (Suppl. S610.
84. Nii M, Hamilton RM, Fenwick L, Kingdom JC, Roman KS, Jaeggi ET. Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography. Heart 2006 92 : 1831 1837.
85. Mevorach D, Eldachal U, Rein A. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block. Curr Opin Rheumatol 2009 21 : 478 482.